In a report released yesterday, Patrick Wood from Morgan Stanley maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price target of $280.00.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Patrick Wood has given his Buy rating due to a combination of factors that suggest strong future performance for Becton Dickinson. One of the key reasons is the company’s solid financial results in the first quarter, with organic growth surpassing expectations at 3.9% and operating margins showing notable strength. Additionally, the company is effectively managing foreign exchange headwinds, which demonstrates operational resilience.
Another major factor influencing the Buy rating is Becton Dickinson’s strategic decision to separate its Life Sciences business, which holds significant market positions and enjoys recurring revenues and high margins. This move is expected to allow the company to concentrate on its core operations, potentially enhancing operational efficiency and creating shareholder value. The separation also indicates the management’s commitment to strategic capital allocation, providing a clear catalyst for the stock’s future performance.
In another report released yesterday, Bank of America Securities also reiterated a Buy rating on the stock with a $269.00 price target.
BDX’s price has also changed slightly for the past six months – from $235.780 to $245.060, which is a 3.94% increase.